Success Metrics

Clinical Success Rate
93.0%

Based on 40 completed trials

Completion Rate
93%(40/43)
Active Trials
15(17%)
Results Posted
25%(10 trials)
Terminated
3(3%)

Phase Distribution

Ph phase_4
2
2%
Ph phase_2
6
7%
Ph early_phase_1
1
1%
Ph not_applicable
49
56%
Ph phase_1
7
8%
Ph phase_3
5
6%

Phase Distribution

8

Early Stage

6

Mid Stage

7

Late Stage

Phase Distribution70 total trials
Early Phase 1First-in-human
1(1.4%)
Phase 1Safety & dosage
7(10.0%)
Phase 2Efficacy & side effects
6(8.6%)
Phase 3Large-scale testing
5(7.1%)
Phase 4Post-market surveillance
2(2.9%)
N/ANon-phased studies
49(70.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.0%

40 of 46 finished

Non-Completion Rate

13.0%

6 ended early

Currently Active

15

trials recruiting

Total Trials

88

all time

Status Distribution
Active(20)
Completed(40)
Terminated(6)
Other(22)

Detailed Status

Completed40
unknown22
Recruiting12
Not yet recruiting5
Withdrawn3
Active, not recruiting3

Development Timeline

Analytics

Development Status

Total Trials
88
Active
15
Success Rate
93.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.4%)
Phase 17 (10.0%)
Phase 26 (8.6%)
Phase 35 (7.1%)
Phase 42 (2.9%)
N/A49 (70.0%)

Trials by Status

unknown2225%
withdrawn33%
completed4045%
active_not_recruiting33%
recruiting1214%
terminated33%
not_yet_recruiting56%

Recent Activity

Clinical Trials (88)

Showing 20 of 88 trialsScroll for more
NCT07542717Phase 1

ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer

Not Yet Recruiting
NCT06782464Not Applicable

Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment

Recruiting
NCT06579209Not Applicable

NAD+ Oral Supplement Pilot Intervention in Adult Females

Completed
NCT04571008Not Applicable

Effect of NMN Supplementation on Organ System Biology

Completed
NCT07376031Not Applicable

Cervical Thermal Ablation to Treat Persistent HPV Infection

Completed
NCT07371858Not Applicable

The Effect of Home-Based Exercise on Chronic Kidney Disease Patients

Completed
NCT07322211Not Applicable

A Study to Evaluate the Clinical Performance and Safety of UNICON Silicone Hydrogel Daily Disposable Soft Contact Lenses

Recruiting
NCT07339553Phase 2

Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer.

Not Yet Recruiting
NCT07323693Not Applicable

Clinical Efficacy of Using Bioactive Desensitizer Gel

Completed
NCT02039752

Asan Multivessel Registry

Recruiting
NCT05689502Not Applicable

intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER)

Active Not Recruiting
NCT07239622Phase 2

Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma

Not Yet Recruiting
NCT07176234Not Applicable

The LEADS Trial (Linking Exericise for Advancing Daily Stress Management)

Recruiting
NCT02392455

VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)

Completed
NCT05148286Phase 4

Albumin and Crystalloid Administration in Septic Shock

Recruiting
NCT06935240Not Applicable

Investigation of Effects of Electrical Stimulation in Women With Vaginal Laxity

Recruiting
NCT05623046Not Applicable

Building Emotional Self-Awareness Teletherapy (BEST)

Completed
NCT06885398Not Applicable

Intra Arrest Ventilation in Human Cadavers II

Not Yet Recruiting
NCT04820855Not Applicable

Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation

Completed
NCT03647098

Survival Outcomes of Lung Cancer

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
88